Sen. Bill Nelson Backs Off on Drug Ads

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

NEW YORK U.S. Sen. Bill Nelson, D-Fla., a key member of the Senate Finance Committee, has backed off from proposing an amendment to eliminate federal tax deductions for pharmaceutical advertising, sources said.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in